Best Life Sciences Platforms and Tools Companies in Michigan, United States
The 47 best Life Sciences Platforms and Tools companies in Michigan, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: NeuMoDx.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Michigan
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | NeuMoDx Developer of a platform for low cost molecular testing | $66M | 99 mo ago | 125 | — | — | — | — | — |
| 2 | Therapeutic Systems Research Laboratories Preclinical CRO driving smarter drug development with integrated services and scientific clarity 32Funding top 37%Innovation top 39%Product top 46%Talent bottom 49% All 7 signals ▾Fundingtop 37% Innovationtop 39% Producttop 46% Talentbottom 49% Techbottom 44% Globalbottom 29% Marketbottom 28% Funding: Raised $51.6M across 32 rounds · 32 rounds over 23 yrs (1.4/yr) Innovation: 9 product lines rank vs industry peers · Fliar Intelligence Index 32/100 | $52M | 15 mo ago | 20 | Elke Lipka President and CEO | Squarespace CommerceSquarespaceTypeScript+12 | Top 50M | — | — |
| 3 | Swift Biosciences Develops and sells reagents for genetic testing and Next Generation Sequencing (NGS). | $35M | 93 mo ago | 41 | — | — | — | 111 patents Optimizing next‑generation sequencing library preparation and polymerase‑based DNA processing. | — |
| 4 | Accuri Cytometers Cell Analysis Flow Cytometers | $31M | 193 mo ago | 13 | — | — | — | 53 patents Automated plate handling, data acquisition, and networking for flow cytometry instruments | — |
| 5 | Akadeum Life Sciences Provider of a technology platform for cell sorting | $26M | 16 mo ago | 26 26 → 16 (-38%) | Brandon McNaughton Chief Executive Officer & Co-Founder | Cart FunctionalityWooCommerceWordPress+24 | Top 5M | — | — |
| 6 | Rubicon Genomics Provider of reagents and kits for pre-analytical amplification technologies | $13M | 133 mo ago | 33 | — | — | — | 68 patents DNA library preparation, barcoding, and methylation analysis via multiplexed amplification | — |
| 7 | Upkara Developer of a biopreservation technology for therapeutics, vaccines and reagents | $13M | 39 mo ago | 13 13 → 22 (+69%) | Pravansu Mohanty Founder | — | — | 42 patents Cryopreservation and ambient-temperature storage/delivery of concentrated bioactive lipid formulations | — |
| 8 | Tissue Regeneration Systems Pioneering skeletal reconstruction through tissue regeneration systems | $11M | 134 mo ago | 6 | — | — | — | — | — |
| 9 | AGI Dermatics Tools for DNA repair | $10M | 220 mo ago | — | Dan Yarosh Founder & CEO | — | — | — | — |
| 10 | H3D High-performance imaging spectrometers revolutionizing gamma-ray source identification and localization 35AI top 15%Patents top 46%Funding top 49%Talent bottom 49% All 9 signals ▾AItop 15% Patentstop 46% Fundingtop 49% Talentbottom 49% Productbottom 48% Globalbottom 41% Marketbottom 39% Innovationbottom 39% Techbottom 35% AI: Holds AI/ML patents (G06N-family CPC) Patents: 19 patents matched (strict assignee match) · 6 filings since 2022 vs 13 in 2017-21 rank vs industry peers · Fliar Intelligence Index 35/100 | $10M | 7 mo ago | 31 | Weiyi Wang Research And Development Director | Apple iCloud MailUbuntuYouTube+4 | Top 10M | 19 patents Coded-aperture X‑ray/gamma imaging and 3‑D radiation source localization systems. | 1 launch |
| 11 | Aquaro Histology Developer of automated section mounting system for histology | $10M | 105 mo ago | 12 | Vincent A Alessi Co-Founder & CSO | — | — | 8 patents Automated slide mounting systems for biological specimen preparation in histology labs. | — |
| 12 | NOTA Laboratories Provider of Nitric oxide-based therapies for chronic rhinosinusitis | $8M | 15 mo ago | 13 | Mark Meyerhoff Co-Founder & CTO | — | — | — | — |
| 13 | Arbor Biosciences Provider of microarrays for analyzing DNA | $4M | 166 mo ago | 34 | Erdogan Gulari Co-Founder & Managing Partner | Cart FunctionalityWooCommerceWordPress+34 | Top 10M | — | 2 launchs |
| 14 | Functional Fluidics Developer of microfluidics-based assays to study blood disorders | $4M | 22 mo ago | 19 | Patrick Hines Founder & CEO | — | — | 5 patents In vivo cellular assay platforms for hypoxia effect assessment in biomedical research | — |
| 15 | Biosavita Developer of yeast platform to produce antibodies against infectious diseases | $3M | 158 mo ago | — | Nalini Motwani Founder & President | — | — | — | — |
| 16 | ProVerde Labs Cannabis and hemp testing laboratory providing analytical and consulting services | $3M | 98 mo ago | 16 16 → 12 (-25%) | Christopher Hudalla Founder and CSO | Cart FunctionalityWordPressMySQL+15 | Top 50M | — | — |
| 17 | Proteos Recombinant protein production CRO providing tailored solutions and diverse expertise | $3M | 190 mo ago | 17 | — | WordPressMySQLPHP+16 | Top 50M | — | 2 job openings |
| 18 | HighRes Biosolutions Provider of dynamic scheduling software, and lab automation instruments | $2M | 132 mo ago | 220 | Louis Guarracina Founder and CTO | HubSpot CMS HubEnvoycore-js+19 | Top 10M | 116 patents Automated liquid handling and assay robotics for high‑throughput laboratory testing | — |
| 19 | Oxford Biomedical Research Biomedical research tools for oxidative stress and chronic inflammation analysis | $2M | 61 mo ago | — | — | — | — | — | — |
| 20 | Forever Labs Provider of stem cell storage and preservation services | $2M | 99 mo ago | 9 | — | Shogun Page BuilderLayoutHubShopify+34 | Top 50M | 49 patents Isolation and purification of extracellular vesicles for biomedical diagnostics and therapeutics | — |
| 21 | 3D Biomatrix Spheroid cultures for cancer research, stem cell research, and drug discovery. | $2M | 157 mo ago | 7 | Mahendra Ramsinghani Co-Founder | — | — | 6 patents Microfluidic hanging-drop platforms for 3D cell culture and spheroid formation | — |
| 22 | RealBio Technology Innovative 3D tissue culture bioreactor systems for advanced research | $2M | 153 mo ago | 10 | — | — | — | 5 patents In vitro cancer metastasis modeling and microfluidic liquid‑handling devices for bioassays | — |
| 23 | Biophotonic Solutions Ultrafast lasers and solutions for scientific, biomedical, and industrial applications | $1M | 152 mo ago | 5 | Marcos Dantus Founder | — | — | — | — |
| 24 | Neogen Solutions for food and animal safety, diagnostics, and genomics | $700K | 457 mo ago | 2,640 2,640 → 2,368 (-10%) | — | Cart FunctionalityOptimizely Content ManagementApple iCloud Mail+28 | Top 500k | 224 patents Diagnostic and analytical testing devices for sample preparation, detection, and mycotoxin analysis | — |
| 25 | LifeMagnetics Developer of new ferrofluidic nanomaterials | $429K | 103 mo ago | 6 | — | — | — | — | — |
| 26 | Stabilux Biosciences Develops fluorophores for flow cytometry | $256K | 71 mo ago | 14 | Yoke Khin Yap Founder | — | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in Michigan
#1
Series A · Ann Arbor, Michigan · founded 2011 · 31 employees$10.1Mraised▾
High-performance imaging spectrometers revolutionizing gamma-ray source identification and localization. The company specializes in advanced radiation detection technology, offering solutions for nuclear power, CBRNE defense, waste management, safeguards, medical applications, and environmental monitoring. They provide imaging spectrometers, spectrometers, handheld directional RIIDs, and custom systems. Their cutting-edge CZT technology enables fast startup, compact design, industry-leading energy resolution, efficient imaging, and a user-friendly interface. They focus on customer needs, offering complete solutions for identifying, quantifying, and localizing sources. Their products are used in nuclear power plants and by emergency responders worldwide. They offer hardware and software solutions, including SourceTerm RMS. The company's technology supports various applications, including nuclear power plant contamination cleanup, CBRNE response, environmental monitoring, defense, and medical imaging.
- Dec 2025Grant (prize money)$1.4M
- Jul 2024Grant (prize money)$206.5K
- Jun 2022Grant (prize money)$1.4M
- Jun 2021Grant (prize money)$1.4M
#2
Funding Raised · Ann Arbor, Michigan · founded 1997 · 20 employees$51.6Mraised▾
Preclinical CRO driving smarter drug development with integrated services and scientific clarity. Focused on helping pharmaceutical, biotech, and academic teams advance early drug candidates. They offer integrated support across formulation development, bioanalysis, PK/ADME, toxicology, drug delivery technologies, and strategic consulting. Services are customized to meet timelines and therapeutic needs. They provide tailored approaches to improve solubility, enhance stability, and meet delivery requirements. High-sensitivity drug quantification using HPLC and LC-MS/MS is used for pharmacokinetic, safety, and toxicology studies. Planning and guidance are offered to close knowledge gaps, align with regulatory needs, and support clear decision-making. Studies are designed to assess how compounds are absorbed, distributed, metabolized, and eliminated, along with early insights into toxicology. Support is available for novel delivery systems including MAP technology. They combine scientific insight with practical experience to help move programs forward, guided by collaboration, transparency, and a strong track record in early development.
- May 2025Grant (prize money)$1.6M
- Mar 2025Grant (prize money)$299.6K
- Mar 2025Grant (prize money)$6M
- Aug 2023Grant (prize money)$1.3M
#3
Series C · Ann Arbor, Michigan · founded 2014 · 26 employees$26.1Mraised▾
Provider of a technology platform for cell sorting. The company offers a microbubble cell separation platform by using Cell Separation and Buoyancy Activated Cell Sorting (BACS) technology which is used in purifying cells from blood and tissues for research or diagnostics areas.
- Apr 2025Series C$20M
- May 2023Series B$6M
- Oct 2021Series B$17.5M
- Dec 2019Series A—
#4
Seed · Ann Arbor, Michigan · founded 2014 · 13 employees$7.5Mraised▾
Provider of Nitric oxide-based therapies for chronic rhinosinusitis. The technology increases the production of nitric oxide that provides natural antimicrobial action in the sinus airways and maintains the antimicrobial and antiviral equilibrium to fight infections. It is applicable for other disorders related to respiratory tract infections such as COPD and cystic fibrosis.
- Apr 2025Grant (prize money)$1.7M
- Apr 2022Seed—
- Apr 2022Grant (prize money)—
- Sep 2019Grant (prize money)$1.7M
#5
Series A · Detroit, Michigan · founded 2013 · 19 employees$3.6Mraised▾
Developer of microfluidics-based assays to study blood disorders. The company uses microfluidic channels coated with various types of substrates and markers to simulate blood flow in vivo and then utilize high-end analytical methods to study the behavior of the cells under various controlled conditions. The assay paradigms include flow adhesion, whole blood thrombosis assays, flow adhesion dynamics, a reversal of flow adhesion, etc. The company currently offers its expertise to clients for drug discovery and companion diagnostics development for blood disorders such as sickle cell disease, and a wide range of clotting and bleeding defects.
- Sep 2024Grant (prize money)$265.3K
- Dec 2023Series A—
- Jan 2021Series A$3.4M
- Sep 2020Grant (prize money)—
#6
Series A · Ann Arbor, Michigan · founded 2014 · 13 employees$13Mraised▾
Developer of a biopreservation technology intended to eliminate the cold chain requirements of therapeutics, vaccines, and reagents. The company provides an anhydrobiotic vitrification technology that eliminates the need for temperature control, also its rapid stabilization process preserves products in a proprietary medium, protecting them from temperature extremes, along with its technology enables biologics, vaccines, nucleic acids, blood products, and others, to be stored at ambient and varying temperatures without impact on function, enabling healthcare providers to eliminate reliance on cold chain storage and distribution.
#7
Acquired · Ann Arbor, Michigan · founded 2012 · 125 employees$66Mraised▾
NeuMoDx is developing a patent-pending platform for low-cost molecular testing. It integrates magnetic particle affinity capture and real-time Polymerase Chain Reaction (PCR) chemistry in a multi-sample microfluidic cartridge. Its lead product NeuMoDx 500 is a molecular IVD system that is a fully automated, random access platform capable of performing RNA and DNA-based assays.
- Apr 2018Series B$20M
- Mar 2018Conventional Debt$4M
- Apr 2016Series B$20M
- Mar 2014Series B$21M
#8
Acqui-Hired · Ann Arbor, Michigan · founded 2010 · 41 employees$35.2Mraised▾
Swift Biosciences is developing new methods and technologies for sample and library prep for next generation sequencing. It offers Accel-NGS DNA library kits ( Illumina NGS & Ion-Torrent platforms) which are designed to accelerate sample preparation for DNA sequencing and deliver more usable data from NGS instruments; Accel-Amplicon Panels for detecting and screening clinically relevant mutations. It also offers myT Primers used in quantitative polymerase chain reaction (qPCR) detection of key cancer mutations.
- Nov 2018Series D$4M
- Jun 2017Series D$12.2M
- Jan 2017Series C$2.9M
- Apr 2016Series C$3.3M
#9
Acquired · Ann Arbor, Michigan · founded 2004 · 13 employees$30.9Mraised▾
Accuri Cytometers developed Accuri C6 which is used in flow cytometry. Its is a compact and portable device to be used by novice and experienced researchers. The system features an software interface, software templates, and reagent kits that guide users new to flow cytometry through workflows for popular applications. Used in Immunophenotyping, Cell finction analysis, gene expression, non-mammalian studies and DNA/Cell cycle analysis.
- Jul 2010Series E$6M
- Jul 2009Series D$4M
- Jul 2008Series C$13M
- 2008Series B$2M
#10
Acquired · Ann Arbor, Michigan · founded 2000 · 33 employees$13Mraised▾
Provider of reagents and kits for pre-analytical amplification technologies. The company has three reagent kits to use with Illumina NGS systems and two kits to use with microarray and PCR systems.
- Jul 2015Series B$2M
- Nov 2007Series B$5.9M
- Jun 2005Series A$1.1M
- Dec 2004Series A$212.5K
#11
Series A · Plymouth, Michigan · founded 2005 · 6 employees$11.1Mraised▾
Pioneering skeletal reconstruction through tissue regeneration systems, the company focuses on developing and commercializing advanced technologies for tissue regeneration. Their technology platform aims to address unmet needs in skeletal reconstruction, offering innovative solutions for patients. The company explores product and market opportunities through foundational research and strategic partnerships. They operate with a business model centered on scientific advancement and clinical application. The company is dedicated to advancing the field of regenerative medicine and improving patient outcomes through cutting-edge research and development. This involves a commitment to innovation and collaboration within the scientific and medical communities.
- May 2015Series A$4.1M
- Aug 2013Series A$4.6M
- Sep 2011Grant (prize money)$849.7K
- May 2011Grant (prize money)$203.3K
#12
Deadpooled · Ann Arbor, Michigan · founded 2013 · 12 employees$9.8Mraised▾
Developer of automated section mounting system for histology
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Michigan is moving
A read on the academic research around Bioinformatics in Michigan — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 329 papers.
- University of Michigan184
- Michigan State University88
- Michigan Medicine35
- University of Michigan–Ann Arbor32
- Michigan United15
- Gene1→10
- Function (biology)1→5
- Genome2→4
- Gene1→6
- Cancer1→5
- Gut flora1→3
- Microbiome2→4
- Genome-wide association study1→3
- Disease2→5
- Cell1→3
- Cancer2→4
- Biomarker1→3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.